Clinical Trial Update: A Study of [18]F-PSMA-1007 in Patients With Known or Suspected Metastatic Prostate Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating [18]F-PSMA-1007 in patients with known or suspected metastatic prostate cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• [18]F-PSMA-1007

Snippet

Sponsor: AHS Cancer Control Alberta | Conditions: Oncology, Prostate Cancer | Phase 2 | Status: TERMINATED